This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Kapsogeorgou EK., Tzioufas AG. Autoantibodies in Autoimmune Diseases: Clinical and Critical Evaluation. Isr Med Assoc J. 2016;18:519–524.KapsogeorgouEK.TzioufasAGAutoantibodies in Autoimmune Diseases: Clinical and Critical Evaluation201618519524Search in Google Scholar
Lerner A, Jeremias P, Matthias T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. Int J Celiac Dis. 2016;3(4); DOI:10.12691/ijcd-3-4-8.LernerAJeremiasPMatthiasTThe World Incidence and Prevalence of Autoimmune Diseases is Increasing20163410.12691/ijcd-3-4-8Open DOISearch in Google Scholar
Cooper GS, Bynum MLK, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3–4); DOI:10.1016/j.jaut.2009.09.008.CooperGSBynumMLKSomersECRecent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases2009333–410.1016/j.jaut.2009.09.008278342219819109Open DOISearch in Google Scholar
Singh RR, Yen EY. SLE mortality remains disproportionately high, despite improvements over the last decade. Lupus. 2018;27(10); DOI:10.1177/0961203318786436.SinghRRYenEYSLE mortality remains disproportionately high, despite improvements over the last decade2018271010.1177/0961203318786436608272730016928Open DOISearch in Google Scholar
Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2); DOI:10.1097/BOR.0000000000000480.StojanGPetriMEpidemiology of systemic lupus erythematosus: an update201830210.1097/BOR.0000000000000480602654329251660Open DOISearch in Google Scholar
Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56(11); DOI:10.1093/rheumatology/kex260.ReesFDohertyMGraingeMJLanyonPZhangWThe worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies2017561110.1093/rheumatology/kex26028968809Open DOISearch in Google Scholar
Montero-López E, Santos-Ruiz A, Navarrete-Navarrete N, Ortego-Centeno N, Pérez-García M, Peralta-Ramírez MI. The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus. Lupus. 2016;25(13); DOI:10.1177/0961203316642313.Montero-LópezESantos-RuizANavarrete-NavarreteNOrtego-CentenoNPérez-GarcíaMPeralta-RamírezMIThe effects of corticosteroids on cognitive flexibility and decision-making in women with lupus2016251310.1177/096120331664231327055522Open DOISearch in Google Scholar
Christopeit M, Schendel M, Föll J, Müller LP, Keysser G, Behre G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia. 2008;22(5); DOI:10.1038/sj.leu.2404996.ChristopeitMSchendelMFöllJMüllerLPKeysserGBehreGMarked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L200822510.1038/sj.leu.240499617972956Open DOISearch in Google Scholar
Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice. Biol Blood Marrow Transplant. 2008;14(6); DOI:10.1016/j.bbmt.2008.01.006.EzquerFEEzquerMEParrauDBCarpioDYañezAJCongetPASystemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice200814610.1016/j.bbmt.2008.01.00618489988Open DOISearch in Google Scholar
Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, Noël D. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5); DOI:10.7150/thno.21072.CosenzaSToupetKMaumusMLuz-CrawfordPBlanc-BrudeOJorgensenCNoëlDMesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis20188510.7150/thno.21072583594529507629Open DOISearch in Google Scholar
Eleuteri S, Fierabracci A. Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications. Int J Mol Sci. 2019;20(18); DOI:10.3390/ijms20184597.EleuteriSFierabracciAInsights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications2019201810.3390/ijms20184597677023931533317Open DOISearch in Google Scholar
Sharma J, Hampton JM, Valiente GR, Wada T, Steigelman H, Young MC, Spurbeck RR, Blazek AD, Bösh S, Jarjour WN, Young NA. Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus. Front Immunol. 2017;8; DOI:10.3389/fimmu.2017.00526.SharmaJHamptonJMValienteGRWadaTSteigelmanHYoungMCSpurbeckRRBlazekADBöshSJarjourWNYoungNATherapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus2017810.3389/fimmu.2017.00526Open DOISearch in Google Scholar
GfK Roper. Lupus Awareness Survey for the Lupus Foundation of America. GfK Roper Public Aff Corp Commun. 2012.GfK RoperGfK Roper Public Aff Corp Commun2012Search in Google Scholar
MichetI CJ, McKenna CH, Elveback LR, Kaslov RA, Kurland LT. Epidemiology of Systemic Lupus Erythematosus and Other Connective Tissue Diseases in Rochester, Minnesota, 1950 Through 1979. Mayo Clin Proc. 1985;60(2); DOI:10.1016/S0025-6196(12)60294-8.MichetICJMcKennaCHElvebackLRKaslovRAKurlandLTEpidemiology of Systemic Lupus Erythematosus and Other Connective Tissue Diseases in Rochester, Minnesota, 1950 Through 1979198560210.1016/S0025-6196(12)60294-8Open DOISearch in Google Scholar
Flower C, Hennis AJM, Hambleton IR, Nicholson GD, Liang MH. Systemic lupus erythematosus in an Afro-Caribbean population: Incidence, clinical manifestations and survival in the Barbados national lupus registry. Arthritis Care Res (Hoboken). 2012; DOI:10.1002/acr.21656.FlowerCHennisAJMHambletonIRNicholsonGDLiangMHSystemic lupus erythematosus in an Afro-Caribbean population: Incidence, clinical manifestations and survival in the Barbados national lupus registry201210.1002/acr.21656Open DOISearch in Google Scholar
Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, Rampudda M, Canova M, Doria A. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201.ZenMGhirardelloAIaccarinoLTononMCampanaCArientiSRampuddaMCanovaMDoriaAHormones, immune response, and pregnancy in healthy women and SLE patients2010140187201Search in Google Scholar
Azevedo PC, Murphy G, Isenberg DA. Pathology of Systemic Lupus Erythematosus: The Challenges Ahead. In: ; 2014. DOI:10.1007/978-1-4939-0326-9_1.AzevedoPCMurphyGIsenbergDAIn: ;201410.1007/978-1-4939-0326-9_1Open DOISearch in Google Scholar
Ruperto N, Hanrahan L, Alarcón G, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5); DOI:10.1177/0961203310388445.RupertoNHanrahanLAlarcónGInternational consensus for a definition of disease flare in lupus201120510.1177/0961203310388445Open DOISearch in Google Scholar
Fernandez D, Kirou KA. What Causes Lupus Flares? Curr Rheumatol Rep. 2016;18(3); DOI:10.1007/s11926-016-0562-3.FernandezDKirouKAWhat Causes Lupus Flares?201618310.1007/s11926-016-0562-3Open DOISearch in Google Scholar
Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2017;29(5); DOI:10.1097/BOR.0000000000000411.ChenLMorrisDLVyseTJGenetic advances in systemic lupus erythematosus: an update201729510.1097/BOR.0000000000000411Open DOISearch in Google Scholar
Sullivan KE. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am. 2000;26(2); DOI:10.1016/S0889-857X(05)70137-X.SullivanKEGenetics of systemic lupus erythematosus200026210.1016/S0889-857X(05)70137-XOpen DOISearch in Google Scholar
James JA, Robertson JM. Lupus and Epstein-Barr. Curr Opin Rheumatol. 2012;24(4); DOI:10.1097/BOR.0b013e3283535801.JamesJARobertsonJMLupus and Epstein-Barr201224410.1097/BOR.0b013e3283535801356234822504579Open DOISearch in Google Scholar
Munoz LE, Gaipl US, Franz S, Sheriff A, Voll RE, Kalden JR, Herrmann M. SLE—a disease of clearance deficiency? Rheumatology. 2005;44(9); DOI:10.1093/rheumatology/keh693.MunozLEGaiplUSFranzSSheriffAVollREKaldenJRHerrmannMSLE—a disease of clearance deficiency?200544910.1093/rheumatology/keh69315928001Open DOISearch in Google Scholar
Jung J-Y, Suh C-H. Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker. Int J Rheum Dis. 2015;18(3); DOI:10.1111/1756-185X.12568.JungJ-YSuhC-HIncomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker201518310.1111/1756-185X.1256825884792Open DOISearch in Google Scholar
Zharkova O, Celhar T, Cravens PD, Satterthwaite AB, Fairhurst A-M, Davis LS. Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology. 2017;56(suppl_1); DOI:10.1093/rheumatology/kew427.ZharkovaOCelharTCravensPDSatterthwaiteABFairhurstA-MDavisLSPathways leading to an immunological disease: systemic lupus erythematosus201756suppl_110.1093/rheumatology/kew427541097828375453Open DOISearch in Google Scholar
Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol. 2017;13(5); DOI:10.1038/nrrheum.2017.43.MorelLImmunometabolism in systemic lupus erythematosus201713510.1038/nrrheum.2017.4328360423Open DOISearch in Google Scholar
Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262(5); DOI:10.1111/j.1365-2796.2007.01844.x.Le BlancKRingdénOImmunomodulation by mesenchymal stem cells and clinical experience2007262510.1111/j.1365-2796.2007.01844.x17949362Open DOISearch in Google Scholar
Tyndall A, Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis. 1996;55(3); DOI:10.1136/ard.55.3.149.TyndallAGratwohlAHaemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases199655310.1136/ard.55.3.14910101168712875Open DOISearch in Google Scholar
Zhu Y, Feng X. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus. Stem Cell Res Ther. 2018;9(1); DOI:10.1186/s13287-018-0898-x.ZhuYFengXGenetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus20189110.1186/s13287-018-0898-x596846229793537Open DOISearch in Google Scholar
Sun L, Zhang H, Feng X, Hou Y, Lu L, Fan L. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007;16(2); DOI:10.1177/0961203306075793.SunLZhangHFengXHouYLuLFanLAbnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus200716210.1177/096120330607579317402368Open DOISearch in Google Scholar
Fathollahi A, Gabalou NB, Aslani S. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder. Lupus. 2018;27(7); DOI:10.1177/0961203318768889.FathollahiAGabalouNBAslaniSMesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder201827710.1177/096120331876888929631514Open DOISearch in Google Scholar
Wang D, Sun L. Systemic Lupus Erythematosus. In: Chen X. D., ed. A Roadmap to Non-Hematopoietic Stem Cell-Based Therapeutics. Academic Press.; 2019:143–172.WangDSunLSystemic Lupus ErythematosusIn:ChenX. D.ed.Academic Press201914317210.1016/B978-0-12-811920-4.00007-0Search in Google Scholar
Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, Lu L, Zeng X, Sun L. Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus. Clin Dev Immunol. 2012;2012; DOI:10.1155/2012/826182.TangYMaXZhangHGuZHouYGilkesonGSLuLZengXSunLGene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus2012201210.1155/2012/826182343314222966240Open DOISearch in Google Scholar
Xu J. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus. In: ; 2018. DOI:10.1007/5584_2018_212.XuJIn: ;201810.1007/5584_2018_21229767288Open DOISearch in Google Scholar
Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, Mönckeberg G, Figueroa F. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus. 2010;19(3); DOI:10.1177/0961203309348983.CarrionFNovaERuizCDiazFInostrozaCRojoDMönckebergGFigueroaFAutologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients201019310.1177/096120330934898319919974Open DOISearch in Google Scholar
Barbado J, Tabera S, Sánchez A, García-Sancho J. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018;27(13); DOI:10.1177/0961203318804922.BarbadoJTaberaSSánchezAGarcía-SanchoJTherapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis2018271310.1177/096120331880492230290717Open DOISearch in Google Scholar
Wallace DJ. The evolution of drug discovery in systemic lupus erythematosus. Nat Rev Rheumatol. 2015;11(10); DOI:10.1038/nrrheum.2015.86.WallaceDJThe evolution of drug discovery in systemic lupus erythematosus2015111010.1038/nrrheum.2015.8626122951Open DOISearch in Google Scholar
Liang J, Sun L. Mesenchymal stem cells transplantation for systemic lupus erythematosus. Int J Rheum Dis. 2015;18(2); DOI:10.1111/1756-185X.12531.LiangJSunLMesenchymal stem cells transplantation for systemic lupus erythematosus201518210.1111/1756-185X.1253125611801Open DOISearch in Google Scholar
Fors Nieves CE, Izmirly PM. Mortality in Systemic Lupus Erythematosus: an Updated Review. Curr Rheumatol Rep. 2016;18(4); DOI:10.1007/s11926-016-0571-2.Fors NievesCEIzmirlyPMMortality in Systemic Lupus Erythematosus: an Updated Review201618410.1007/s11926-016-0571-226984805Open DOISearch in Google Scholar
Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek D V., Schoeberlein A. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid. Best Pract Res Clin Obstet Gynaecol. 2016;31; DOI:10.1016/j.bpobgyn.2015.07.006.Joerger-MesserliMSMarxCOppligerBMuellerMSurbekD V.SchoeberleinAMesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid20163110.1016/j.bpobgyn.2015.07.00626482184Open DOISearch in Google Scholar
Araújo AB, Salton GD, Furlan JM, Schneider N, Angeli MH, Laureano A M, Silla L, Passos EP, Paz AH. Comparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy. 2017;19(5); DOI:10.1016/j.jcyt.2017.03.001.AraújoABSaltonGDFurlanJMSchneiderNAngeliMHLaureanoAMSillaLPassosEPPazAHComparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord201719510.1016/j.jcyt.2017.03.00128343898Open DOISearch in Google Scholar
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F., Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4); DOI:10.1080/14653240600855905.DominiciMLe BlancKMuellerISlaper-CortenbachIMariniF.KrauseDSDeansRJKeatingAProckopDJHorwitzEMMinimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement20068410.1080/1465324060085590516923606Open DOISearch in Google Scholar
Friedenstein AJ., Gorskaja JF., Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267–274;FriedensteinAJ.GorskajaJF.KulaginaNNFibroblast precursors in normal and irradiated mouse hematopoietic organs19764267274Search in Google Scholar
Calloni R, Cordero EAA, Henriques JAP, Bonatto D. Reviewing and Updating the Major Molecular Markers for Stem Cells. Stem Cells Dev. 2013;22(9); DOI:10.1089/scd.2012.0637.CalloniRCorderoEAAHenriquesJAPBonattoDReviewing and Updating the Major Molecular Markers for Stem Cells201322910.1089/scd.2012.0637362977823336433Open DOISearch in Google Scholar
Choi EW, Lee HW, Shin IS, Park JH, Yun TW, Youn HY, Kim S-J. Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus. Cell Transplant. 2016;25(6); DOI:10.3727/096368915X689442.ChoiEWLeeHWShinISParkJHYunTWYounHYKimS-JComparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus201625610.3727/096368915X68944226377835Open DOISearch in Google Scholar
Shin H, Ryu HH, Kwon O, Park B-S, Jo SJ. Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study. Int J Dermatol. 2015;54(6); DOI:10.1111/ijd.12650.ShinHRyuHHKwonOParkB-SJoSJClinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study201554610.1111/ijd.1265025777970Open DOISearch in Google Scholar
Mita T, Furukawa-Hibi Y, Takeuchi H, Hattori H, Yamada K, Hibi H, Ueda M, Yamamoto A. Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer's disease. Behav Brain Res. 2015;293; DOI:10.1016/j.bbr.2015.07.043.MitaTFurukawa-HibiYTakeuchiHHattoriHYamadaKHibiHUedaMYamamotoAConditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer's disease201529310.1016/j.bbr.2015.07.04326210934Open DOISearch in Google Scholar
Tracy SA, Ahmed A, Tigges JC, Ericsson M, Pal AK, Zurakowski D, Fauza DO. A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid. J Pediatr Surg. 2019;54(1); DOI:10.1016/j.jpedsurg.2018.10.020.TracySAAhmedATiggesJCEricssonMPalAKZurakowskiDFauzaDOA comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid201954110.1016/j.jpedsurg.2018.10.02030361074Open DOISearch in Google Scholar
Harris L, Vangsness CT. Mesenchymal Stem Cell Levels of Human Spinal Tissues. Spine (Phila Pa 1976). 2018;43(9); DOI:10.1097/BRS.0000000000002401.HarrisLVangsnessCTMesenchymal Stem Cell Levels of Human Spinal Tissues201843910.1097/BRS.000000000000240128885289Open DOISearch in Google Scholar
Davies JE, Walker JT, Keating A. Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells. Stem Cells Transl Med. 2017;6(7); DOI:10.1002/sctm.16-0492.DaviesJEWalkerJTKeatingAConcise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells20176710.1002/sctm.16-0492568977228488282Open DOISearch in Google Scholar
Ding D-C, Chang Y-H, Shyu W-C, Lin S-Z. Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy. Cell Transplant. 2015;24(3); DOI:10.3727/096368915X686841.DingD-CChangY-HShyuW-CLinS-ZHuman Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy201524310.3727/096368915X68684125622293Open DOISearch in Google Scholar
La Rocca G. Novel Immunomodulatory Markers Expressed by Human WJ-MSC: an Updated Review in Regenerative and Reparative Medicine. Open Tissue Eng Regen Med J. 2012;5(1); DOI:10.2174/1875043501205010050.La RoccaGNovel Immunomodulatory Markers Expressed by Human WJ-MSC: an Updated Review in Regenerative and Reparative Medicine20125110.2174/1875043501205010050Open DOISearch in Google Scholar
Tong CK, Vellasamy S, Chong Tan B, Abdullah M, Vidyadaran S, Fong Seow H, Ramasamy R. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int. 2011;35(3); DOI:10.1042/CBI20100326.TongCKVellasamySChong TanBAbdullahMVidyadaranSFong SeowHRamasamyRGeneration of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method201135310.1042/CBI2010032620946106Open DOISearch in Google Scholar
Rubtsov Y, Goryunov K, Romanov A, Suzdaltseva Y, Sharonov G, Tkachuk V. Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1. Stem Cells Int. 2017;2017; DOI:10.1155/2017/6516854.RubtsovYGoryunovKRomanovASuzdaltsevaYSharonovGTkachukVMolecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-12017201710.1155/2017/6516854551849728761447Open DOISearch in Google Scholar
Pistoia V, Raffaghello L. Mesenchymal stromal cells and autoimmunity. Int Immunol. 2017;29(2); DOI:10.1093/intimm/dxx008.PistoiaVRaffaghelloLMesenchymal stromal cells and autoimmunity201729210.1093/intimm/dxx00828338763Open DOISearch in Google Scholar
Che N, Li X, Zhou S, Liu R, Shi D, Lu L, Sun L. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol. 2012;274(1–2); DOI:10.1016/j.cellimm.2012.02.004.CheNLiXZhouSLiuRShiDLuLSunLUmbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation20122741–210.1016/j.cellimm.2012.02.00422414555Open DOISearch in Google Scholar
Asari S, Itakura S, Ferreri K, Liu C-P, Kuroda Y, Kandeel F, Mullen Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol. 2009;37(5); DOI:10.1016/j.exphem.2009.01.005.AsariSItakuraSFerreriKLiuC-PKurodaYKandeelFMullenYMesenchymal stem cells suppress B-cell terminal differentiation200937510.1016/j.exphem.2009.01.005274766119375651Open DOISearch in Google Scholar
Ribeiro A, Laranjeira P, Mendes S, Velada I, Leite C, Andrade P, Santos F, Henriques A, Grãos M, Cardoso CMP, Martinho A, Pais Ml, da Silva C, Cabral J, Trindade H, Paiva A. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther. 2013;4(5); DOI:10.1186/scrt336.RibeiroALaranjeiraPMendesSVeladaILeiteCAndradePSantosFHenriquesAGrãosMCardosoCMPMartinhoAPaisMlda SilvaCCabralJTrindadeHPaivaAMesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells20134510.1186/scrt336385470224406104Open DOISearch in Google Scholar
Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin M-N, Forner K, Basik M, Galipeau J. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner. J Immunol. 2009;182(10); DOI:10.4049/jimmunol.0803962.RafeiMCampeauPMAguilar-MahechaABuchananMWilliamsPBirmanEYuanSYoungYKBoivinM-NFornerKBasikMGalipeauJMesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner20091821010.4049/jimmunol.080396219414750Open DOISearch in Google Scholar
Cheng R-J, Xiong A-J, Li Y-H, Pan S-Y, Zhang Q-P, Zhao Y, Liu Y, Marion TN. Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients. Front Cell Dev Biol. 2019;7; DOI:10.3389/fcell.2019.00285.ChengR-JXiongA-JLiY-HPanS-YZhangQ-PZhaoYLiuYMarionTNMesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients2019710.3389/fcell.2019.00285687414431799252Open DOISearch in Google Scholar
Perez-Hernandez J, Redon J, Cortes R. Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus. Int J Mol Sci. 2017;18(4); DOI:10.3390/ijms18040717.Perez-HernandezJRedonJCortesRExtracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus201718410.3390/ijms18040717541230328350323Open DOISearch in Google Scholar
Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6); DOI:10.1038/aps.2017.12.LuanXSansanaphongprichaKMyersIChenHYuanHSunDEngineering exosomes as refined biological nanoplatforms for drug delivery201738610.1038/aps.2017.12552018428392567Open DOISearch in Google Scholar
Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4); DOI:10.1083/jcb.201211138.RaposoGStoorvogelWExtracellular vesicles: Exosomes, microvesicles, and friends2013200410.1083/jcb.201211138357552923420871Open DOISearch in Google Scholar
Mathivanan S, Simpson RJ. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics. 2009;9(21); DOI:10.1002/pmic.200900351.MathivananSSimpsonRJExoCarta: A compendium of exosomal proteins and RNA200992110.1002/pmic.20090035119810033Open DOISearch in Google Scholar
Qiu G, Zheng G, Ge M, Wang J, Huang R, Shu Q, Xu J. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther. 2018;9(1); DOI:10.1186/s13287-018-1069-9.QiuGZhengGGeMWangJHuangRShuQXuJMesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs20189110.1186/s13287-018-1069-9624982630463593Open DOISearch in Google Scholar
Celhar T, Fairhurst A-M. Modelling clinical systemic lupus erythematosus: similarities, differences and success stories. Rheumatology. December 2016; DOI:10.1093/rheumatology/kew400.CelharTFairhurstA-MModelling clinical systemic lupus erythematosus: similarities, differences and success storiesDecember201610.1093/rheumatology/kew400541099028013204Open DOISearch in Google Scholar
Li W, Titov AA, Morel L. An update on lupus animal models. Curr Opin Rheumatol. 2017;29(5); DOI:10.1097/BOR.0000000000000412.LiWTitovAAMorelLAn update on lupus animal models201729510.1097/BOR.0000000000000412581539128537986Open DOISearch in Google Scholar
Xu Y, Zeumer L, Reeves WH, Morel L. Induced Murine Models of Systemic Lupus Erythematosus. In: ; 2014. DOI:10.1007/978-1-4939-0326-9_9.XuYZeumerLReevesWHMorelLIn: ;201410.1007/978-1-4939-0326-9_924497358Open DOISearch in Google Scholar
Wang D, Niu L, Feng X, Yuan X, Zhao S, Zhang H, Liang J, Zhao C, Wang H, Hua B, Sun L. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med. 2017;17(3); DOI:10.1007/s10238-016-0427-0.WangDNiuLFengXYuanXZhaoSZhangHLiangJZhaoCWangHHuaBSunLLong-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study201717310.1007/s10238-016-0427-027270729Open DOISearch in Google Scholar
Zhang Y, Xia Y, Ni S, Gu Z, Liu H. Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL/lpr mice. J Thorac Dis. 2014;6:109–117;ZhangYXiaYNiSGuZLiuHTransplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL/lpr mice20146109117Search in Google Scholar
Li X, Wang D, Liang J, Zhang H, Sun L. Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus. Bone Marrow Transplant. 2013;48(4); DOI:10.1038/bmt.2012.184.LiXWangDLiangJZhangHSunLMesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus201348410.1038/bmt.2012.18423064040Open DOISearch in Google Scholar
Jang E, Jeong M, Kim S, Jang K, Kang B-K, Lee DY, Bae S-C, Kim KS, Youn J. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development. Cell Transplant. 2016;25(1); DOI:10.3727/096368915X688173.JangEJeongMKimSJangKKangB-KLeeDYBaeS-CKimKSYounJInfusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development201625110.3727/096368915X68817325975931Open DOISearch in Google Scholar
Thiel A, Yavanian G, Nastke M-D, Morales P, Kouris NA, Kimbrel EA, Lanza R. Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis. Sci Rep. 2016;5(1); DOI:10.1038/srep17685.ThielAYavanianGNastkeM-DMoralesPKourisNAKimbrelEALanzaRHuman embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis20165110.1038/srep17685466721326628350Open DOISearch in Google Scholar
Mai S, Zou L, Tian X, Liao X, Luan Y, Han X, Wei Y, Wu Y, Kuang S, Yang Y, Ma J, Chen Q, Yang J. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice. Mol Pharm. 2018;15(5); DOI:10.1021/acs.molpharmaceut.7b01146.MaiSZouLTianXLiaoXLuanYHanXWeiYWuYKuangSYangYMaJChenQYangJDouble-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice201815510.1021/acs.molpharmaceut.7b0114629668284Open DOISearch in Google Scholar
Chang J-W, Hung S-P, Wu H-H, Wu W-M, Yang A-H, Tsai H-L, Yang L-Y, Lee OK. Therapeutic Effects of Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation in Experimental Lupus Nephritis. Cell Transplant. 2011;20(2); DOI:10.3727/096368910X520056.ChangJ-WHungS-PWuH-HWuW-MYangA-HTsaiH-LYangL-YLeeOKTherapeutic Effects of Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation in Experimental Lupus Nephritis201120210.3727/096368910X52005620719085Open DOISearch in Google Scholar
Zhang Z, Feng R, Niu L, Huang S, Deng W, Shi B, Yao G, Chen W, Tang X, Gao X, Feng X, Sun L. Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion through the Activation of iNOS in Lupus-Prone B6.MRL- Fas lpr Mice. Cell Transplant. 2017;26(6); DOI:10.3727/096368917X694660.ZhangZFengRNiuLHuangSDengWShiBYaoGChenWTangXGaoXFengXSunLHuman Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion through the Activation of iNOS in Lupus-Prone B6.MRL- Fas lpr Mice201726610.3727/096368917X694660565774628105982Open DOISearch in Google Scholar
Gu F, Molano I, Ruiz P, Sun L, Gilkeson GS. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clin Immunol. 2012;145(2); DOI:10.1016/j.clim.2012.08.012.GuFMolanoIRuizPSunLGilkesonGSDifferential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice2012145210.1016/j.clim.2012.08.01223041504Open DOISearch in Google Scholar
Che N, Li X, Zhang L, Liu R, Chen H, Gao X, Shi S, Chen W, Sun L. Impaired B Cell Inhibition by Lupus Bone Marrow Mesenchymal Stem Cells Is Caused by Reduced CCL2 Expression. J Immunol. 2014;193(10); DOI:10.4049/jimmunol.1400036.CheNLiXZhangLLiuRChenHGaoXShiSChenWSunLImpaired B Cell Inhibition by Lupus Bone Marrow Mesenchymal Stem Cells Is Caused by Reduced CCL2 Expression20141931010.4049/jimmunol.140003625339674Open DOISearch in Google Scholar
Li T, Xia M, Gao Y, Chen Y, Xu Y. Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther. 2015;15(9); DOI:10.1517/14712598.2015.1051528.LiTXiaMGaoYChenYXuYHuman umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy201515910.1517/14712598.2015.105152826067213Open DOISearch in Google Scholar
Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol. 2011;272(1); DOI:10.1016/j.cellimm.2011.09.010.ZhouCYangBTianYJiaoHZhengWWangJGuanFImmunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes2011272110.1016/j.cellimm.2011.09.010323532622004796Open DOISearch in Google Scholar
Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, Feng X, Sun L. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5); DOI:10.1038/cmi.2015.89.WangDHuangSYuanXLiangJXuRYaoGFengXSunLThe regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus201714510.1038/cmi.2015.89542308426435067Open DOISearch in Google Scholar
Driscoll J, Patel T. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease. J Gastroenterol. 2019;54(9); DOI:10.1007/s00535-019-01599-1.DriscollJPatelTThe mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease201954910.1007/s00535-019-01599-1669826131270691Open DOISearch in Google Scholar
Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1); DOI:10.1080/20013078.2018.1535750.ThéryCWitwerKWAikawaEMinimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines20187110.1080/20013078.2018.1535750632235230637094Open DOISearch in Google Scholar
Chudickova M, Vackova I, Machova Urdzikova L, Jancova P, Kekulova K, Rehorova M, Turnovcova K, Jendelova P, Kubinova S. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury. Int J Mol Sci. 2019;20(18); DOI:10.3390/ijms20184516.ChudickovaMVackovaIMachova UrdzikovaLJancovaPKekulovaKRehorovaMTurnovcovaKJendelovaPKubinovaSThe Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury2019201810.3390/ijms20184516677054531547264Open DOISearch in Google Scholar
Giacoppo S, Thangavelu SR, Diomede F, Bramanti P, Conti P, Trubiani O, Mazzon E. Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37. FASEB J. 2017;31(12); DOI:10.1096/fj.201700524R.GiacoppoSThangaveluSRDiomedeFBramantiPContiPTrubianiOMazzonEAnti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-372017311210.1096/fj.201700524R569038228842429Open DOISearch in Google Scholar
Pouya S, Heidari M, Baghaei K, Asadzadeh Aghdaei H, Moradi A, Namaki S, Zali MR, Hashemi SM. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018;54; DOI:10.1016/j.intimp.2017.11.001.PouyaSHeidariMBaghaeiKAsadzadeh AghdaeiHMoradiANamakiSZaliMRHashemiSMStudy the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis20185410.1016/j.intimp.2017.11.00129112894Open DOISearch in Google Scholar
Katagiri W, Osugi M, Kawai T, Hibi H. First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells. Head Face Med. 2016;12(1); DOI:10.1186/s13005-016-0101-5.KatagiriWOsugiMKawaiTHibiHFirst-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells201612110.1186/s13005-016-0101-5471445926772731Open DOISearch in Google Scholar
Fukuoka H, Suga H. Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms. . Eplasty. 2015;15:e10.FukuokaHSugaHHair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms201515e10Search in Google Scholar
Lauxmann MA, Santucci NE, Autrán-Gómez AM. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak. Int braz j urol. 2020;46(suppl 1); DOI:10.1590/s1677-5538.ibju.2020.s101.LauxmannMASantucciNEAutrán-GómezAMThe SARS-CoV-2 Coronavirus and the COVID-19 Outbreak202046suppl 110.1590/s1677-5538.ibju.2020.s101Open DOISearch in Google Scholar